> ## Content Index
> Fetch the complete content index at: https://www.pennystocks.news/llms.txt
> Use this file to discover other available public pages before exploring further.

# Nexus Advanced Technologies Faces Delisting After Its Reverse Split Backfired
- URL: https://www.pennystocks.news/nxat-nexus-advanced-technologies-faces-delisting-after-its-r/
- Published: 2026-11-21T14:00:12.000Z
- Updated: 2026-11-21T14:00:12.000Z
- Description: The company combined every 30 of its shares into one in August. The stock fell back below Nasdaq's $1.00 minimum anyway — and that same split now disqualifies it from the standard six-month remedy.
- Author: PennyStocksNews Team
- Tags: nasdaq, NXAT

In August, Nexus Advanced Technologies combined every 30 of its shares into one. Within weeks, the stock was back below $1.00 — the floor Nasdaq requires for continued listing. That reverse split is now the reason the company cannot use the standard six-month remedy.

Nexus Advanced Technologies Inc. NASDAQ: NXAT 

Shares closed 144.97% higher at $0.5480, on dollar volume of about $211 million.

For anyone holding the stock, the question is whether a Nasdaq Hearings Panel will give the company enough time and latitude to get back above $1.00\. The company says it intends to present a compliance plan to the panel. It has not said what that plan is.

Nasdaq notified the company on November 11 that its shares had closed below $1.00 for 30 consecutive business days. Normally, a company in that position gets 180 days to fix it. But a Nasdaq rule bars that grace period for any company that did a reverse split in the preceding year. The 1-for-30 split took effect on August 3 — less than four months before the notice arrived.

The company's warrants face the same outcome. Nasdaq requires that the underlying shares stay listed; if the shares go, the warrants go with them.

The appeal deadline was November 18\. The release, filed on November 17, says the company plans to request a hearing. If filed in time, Nasdaq will hold off on suspending trading while the panel considers the case. If not, trading would have been suspended at the open on November 20, and Nasdaq would have filed to remove the securities from listing. The company says there is no assurance it will win the appeal or regain compliance.

The release does not describe what plan the company intends to present to the panel, or how it expects to get the stock back above $1.00 and hold it there.